Medical technology giant **Boston Scientific** is grappling with the fallout from a cyberattack that has caused widespread disruption to its global operations. The company, a leading developer and manufacturer of devices for minimally invasive procedures, disclosed the incident, which has led to network outages and impaired access to essential operating systems and business applications.  ### Operational Impact and Response **Boston Scientific** detected the intrusion on August 25. In an official announcement and a subsequent filing with the U.S. Securities and Exchange Commission (**SEC**), the company stated that the attack has hindered its ability to process and ship customer orders, among other critical functions. Upon identifying the breach, **Boston Scientific** promptly initiated its incident response protocols. This included engaging external cybersecurity experts to assist with the investigation, containment efforts, and the arduous task of remediation. ### Uncertainty Around Restoration While the company is diligently working to restore affected systems, the timeline for a full recovery remains uncertain. The ongoing disruption is expected to continue impacting various aspects of its operations. **Boston Scientific** is a significant player in the medical device industry, boasting 59,000 employees, 13 manufacturing facilities, and a presence in 127 countries. Its annual revenue exceeded $20 billion in 2025. ### Investigation Underway At present, **Boston Scientific** has not publicly disclosed details regarding the nature of the cyberattack, the identity of the threat actor, or whether any sensitive data has been compromised or exfiltrated. There have been no public claims of responsibility from ransomware groups or data extortion actors at the time of reporting. The investigation is ongoing as the company works to determine the full scope, nature, and potential operational or financial consequences of the cybersecurity incident.